Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model

Epilepsy Research

Volumn 85, Issue 1, 2009, Pages 123-127

  Echegoyen, Julio ^a   Armstrong, Caren ^a   Morgan, Robert J ^a   Soltesz, Ivan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CB1; Epilepsy; Rimonabant; Traumatic brain injury

Indexed keywords

CANNABINOID 1 RECEPTOR ANTAGONIST; PENTOBARBITAL; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EPILEPTOGENESIS; HEAD INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SPIKE; TRAUMATIC EPILEPSY;

ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; CRANIOCEREBRAL TRAUMA; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY, POST-TRAUMATIC; PENTOBARBITAL; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 67349209246     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.02.019     Document Type: Article

References (19)

1. Chen K., Neu A., Howard A.L., Foldy C., Echegoyen J., Hilgenberg L., Smith M., Mackie K., and Soltesz I. Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci. 27 (2007) 46-58
2. Coulter D.A., Rafiq A., Shumate M., Gong Q.Z., DeLorenzo R.J., and Lyeth B.G. Brain injury-induced enhanced limbic epileptogenesis: anatomical and physiological parallels to an animal model of temporal lobe epilepsy. Epilepsy Res. 26 (1996) 81-91
3. D'Ambrosio R., Fairbanks J.P., Fender J.S., Born D.E., Doyle D.L., and Miller J.W. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 127 (2004) 304-314
4. Despres J.P., Golay A., and Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353 (2005) 2121-2134
5. Garga N., and Lowenstein D.H. Posttraumatic epilepsy: a major problem in desperate need of major advances. Epilepsy Curr. 6 (2006) 1-5
6. Hauser W.A., Annegers J.F., and Kurland L.T. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 32 (1991) 429-445
7. Howard A.L., Neu A., Morgan R.J., Echegoyen J.C., and Soltesz I. Opposing modifications in intrinsic currents and synaptic inputs in post-traumatic mossy cells: evidence for single-cell homeostasis in a hyperexcitable network. J. Neurophysiol. 97 (2007) 2394-2409
8. Katona I., and Freund T.F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat. Med. 14 (2008) 923-930
9. Kharatishvili I., Immonen R., Grohn O., and Pitkänen A. Quantitative diffusion MRI of hippocampus as a surrogate marker for post-traumatic epileptogenesis. Brain 130 (2007) 3155-3168
10. Kharatishvili I., Nissinen J.P., McIntosh T.K., and Pitkänen A. A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 140 (2006) 685-697
11. Lowenstein D.H., Thomas M.J., Smith D.H., and McIntosh T.K. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12 (1992) 4846-4853
12. Lutz B., and Monory K. Soothing the seizures of children. Nat. Med. 14 (2008) 721-722
13. Monory K., Massa F., Egertova M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J.L., Goebbels S., Nave K.A., During M., Klugmann M., Wolfel B., Dodt H.U., Zieglgansberger W., Wotjak C.T., Mackie K., Elphick M.R., Marsicano G., and Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51 (2006) 455-466
14. Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., and Rosenstock J. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295 (2006) 761-775
15. Pitkänen A., Narkilahti S., Bezvenyuk Z., Haapalinna A., and Nissinen J. Atipamezole, an alpha(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res. 61 (2004) 119-140
16. Santhakumar V., Bender R., Frotscher M., Ross S.T., Hollrigel G.S., Toth Z., and Soltesz I. Granule cell hyperexcitability in the early post-traumatic rat dentate gyrus: the 'irritable mossy cell' hypothesis. J. Physiol. 524 Pt 1 (2000) 117-134
17. Temkin N.R. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42 (2001) 515-524
18. Toth Z., Hollrigel G.S., Gorcs T., and Soltesz I. Instantaneous perturbation of dentate interneuronal networks by a pressure wave-transient delivered to the neocortex. J. Neurosci. 17 (1997) 8106-8117
19. Wallace M.J., Blair R.E., Falenski K.W., Martin B.R., and DeLorenzo R.J. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 307 (2003) 129-137